Funakoshi, Y., Hata, N., Kuga, D., Hatae, R., Sangatsuda, Y., Fujioka, Y., . . . Mizoguchi, M. (2020). ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application. Neurooncol Adv.

Funakoshi, Yusuke, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Kosuke Takigawa, und Masahiro Mizoguchi. "ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma After Approval of Bevacizumab As First-line Application." Neurooncol Adv 2020.

Funakoshi, Yusuke, et al. "ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma After Approval of Bevacizumab As First-line Application." Neurooncol Adv 2020.